ArticleSchizophrenia (Heidelberg, Germany)2025
A dimensional approach to psychosis: identifying cognition, depression, and thought disorder factors in a clinical sample.
Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Traditional classification systems based on broad nosological categories do not adequately capture the high heterogeneity of mental illness. One possible solution to this is to move to a multi-dimensional model of mental illness, as has been proposed by the Research Domain Criteria and Hierarchical Taxonomy of Psychopathology frameworks. In this study, we explored the dimensional structure of psychotic disorders. We focused on the question whether combining measures of psychosis with cognitive and depression-related measures results in meaningful, clinically relevant, and valid latent dimensions in a sample of early psychosis (n = 113) and chronic schizophrenia patients (n = 43, total n = 156). We used exploratory factor analysis to identify the symptom dimensions in the Lausanne Psychosis data, a multi-modal prospective data set that includes a broad behavioral assessment of patients diagnosed with psychotic disorders. We evaluated the validity of these dimensions by regressing them to several functioning measures. Our analysis revealed three dimensions: Cognition, Depression/Negative, and Thought Disorder, explaining 49.2% of the variance. They were related to measures of functioning, the R² ranging between 0.38 and 0.42. This study advances the development of a multi-dimensional characterization of psychotic disorders by identifying three symptom dimensions with predictive validity in people with psychosis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.